Intec Pharma Ltd (NASDAQ: NTEC) CEO Jeffery Meckler talked with Proactive’s Steve Darling at the 12th annual LD Micro Conference. The Jerusalem, Israel-based clinical-stage biopharmaceutical company develops drugs based on its proprietary Accordion Pill platform technology. The innovative Accordion Pill oral drug delivery system boosts the potency of drugs by utilizing efficient gastric retention and specific release mechanism.
Intec Pharma accordion pill technology looking to change the game in drug delivery
Intec Pharma Ltd (NASDAQ: NTEC) CEO Jeffery Meckler talked with Proactive’s Steve Darling at the 12th annual LD Micro Conference. The Jerusalem, Israel-based clinical-stage biopharmaceutical company develops drugs based on its proprietary Accordion Pill platform technology. The innovative Accordion Pill oral drug delivery system boosts the potency of drugs by utilizing efficient gastric retention and specific release mechanism.
![LiL Peep - the last thing i wanna do [INSTRUMENTAL]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_svKrWnEJP2J5YPOMrSUfSyYnKa8lF0YOhlaux1ecNmIYMEkL_i3bKV7NQn0G5ihSUF5LHQ00Rne64NYo0u437mUN_xy1ETi8rzOtinj4ftd2lZ=w680)
0 Comments